Patent · US Active

Soluble guanylate cyclase activators and their use

US9938260B2 · kind B2 · utility

1Cited by

0References

10Claims

0Family size

Assignee

GlaxoSmithKline Intellectual Property Development Limited · GB

Inventors

Nerina Dodic · Les Ulis, FR
Anne Marie Jeanne Bouillot · Les Ulis, FR

Key dates

Filing date	Sep 18, 2015
Grant date	Apr 10, 2018
Priority date	—
Expiry date	Sep 18, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to activators of soluble guanylate cyclase and their use in pharmaceutical compositions, primarily topically administered ophthalmic compositions. The pharmaceutical compositions are useful for reducing intraocular pressure in animals of the mammalian species.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.